Agenus Inc. (AGEN)
USD 1.71
(5.25%)
USD 1.71
(5.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 350.24 Million USD | 346.58% |
| 2022 | 78.42 Million USD | 34.55% |
| 2021 | 58.28 Million USD | 4.59% |
| 2020 | 55.72 Million USD | 138.22% |
| 2019 | 23.39 Million USD | 75.13% |
| 2018 | 13.35 Million USD | -91.81% |
| 2017 | 163.02 Million USD | 24.74% |
| 2016 | 130.68 Million USD | 14.17% |
| 2015 | 114.47 Million USD | 1799.47% |
| 2014 | 6.02 Million USD | -32.03% |
| 2013 | 8.86 Million USD | -75.32% |
| 2012 | 35.91 Million USD | 9.09% |
| 2011 | 32.92 Million USD | -3.72% |
| 2010 | 34.19 Million USD | -31.11% |
| 2009 | 49.64 Million USD | -26.98% |
| 2008 | 67.98 Million USD | -12.33% |
| 2007 | 77.54 Million USD | 2.74% |
| 2006 | 75.47 Million USD | 1710.17% |
| 2005 | 4.16 Million USD | -57.97% |
| 2004 | 9.92 Million USD | -37.47% |
| 2003 | 15.86 Million USD | 2780.4% |
| 2002 | 550.87 Thousand USD | -90.96% |
| 2001 | 6.09 Million USD | 22.45% |
| 2000 | 4.97 Million USD | 65.92% |
| 1999 | 3 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 411.59 Million USD | -76.74% |
| 2024 Q1 | 347.71 Million USD | -0.72% |
| 2023 Q2 | 87.34 Million USD | -0.46% |
| 2023 Q1 | 87.75 Million USD | 11.89% |
| 2023 FY | 350.24 Million USD | 346.58% |
| 2023 Q3 | 89.02 Million USD | 1.92% |
| 2023 Q4 | 350.24 Million USD | 293.44% |
| 2022 FY | 78.42 Million USD | 34.55% |
| 2022 Q4 | 78.42 Million USD | -0.94% |
| 2022 Q3 | 79.17 Million USD | -1.26% |
| 2022 Q2 | 80.18 Million USD | 24.68% |
| 2022 Q1 | 64.31 Million USD | 10.34% |
| 2021 Q2 | 56.85 Million USD | -1.34% |
| 2021 Q1 | 57.62 Million USD | 3.4% |
| 2021 FY | 58.28 Million USD | 4.59% |
| 2021 Q3 | 54.59 Million USD | -3.97% |
| 2021 Q4 | 58.28 Million USD | 6.76% |
| 2020 Q4 | 55.72 Million USD | 51.63% |
| 2020 Q1 | 29.45 Million USD | 25.93% |
| 2020 Q2 | 37.33 Million USD | 26.73% |
| 2020 FY | 55.72 Million USD | 138.22% |
| 2020 Q3 | 36.75 Million USD | -1.55% |
| 2019 Q2 | 22.2 Million USD | 6.47% |
| 2019 Q3 | 23.4 Million USD | 5.38% |
| 2019 FY | 23.39 Million USD | 75.13% |
| 2019 Q4 | 23.39 Million USD | -0.04% |
| 2019 Q1 | 20.86 Million USD | 56.17% |
| 2018 FY | 13.35 Million USD | -91.81% |
| 2018 Q2 | 13.05 Million USD | 1.1% |
| 2018 Q4 | 13.35 Million USD | 1.19% |
| 2018 Q3 | 13.19 Million USD | 1.12% |
| 2018 Q1 | 12.91 Million USD | -92.08% |
| 2017 Q2 | 138.67 Million USD | 3.26% |
| 2017 Q4 | 163.02 Million USD | 13.81% |
| 2017 FY | 163.02 Million USD | 24.74% |
| 2017 Q1 | 134.3 Million USD | 2.77% |
| 2017 Q3 | 143.24 Million USD | 3.3% |
| 2016 Q3 | 126.4 Million USD | 3.38% |
| 2016 Q2 | 122.27 Million USD | 3.35% |
| 2016 Q1 | 118.3 Million USD | 3.35% |
| 2016 FY | 130.68 Million USD | 14.17% |
| 2016 Q4 | 130.68 Million USD | 3.39% |
| 2015 FY | 114.47 Million USD | 1799.47% |
| 2015 Q1 | 11.5 Million USD | 90.86% |
| 2015 Q4 | 114.47 Million USD | 3.41% |
| 2015 Q3 | 110.69 Million USD | 868.72% |
| 2015 Q2 | 11.42 Million USD | -0.65% |
| 2014 Q2 | 7.42 Million USD | -20.64% |
| 2014 Q1 | 9.36 Million USD | 5.57% |
| 2014 FY | 6.02 Million USD | -32.03% |
| 2014 Q3 | 6.71 Million USD | -9.59% |
| 2014 Q4 | 6.02 Million USD | -10.27% |
| 2013 Q4 | 8.86 Million USD | -4.93% |
| 2013 FY | 8.86 Million USD | -75.32% |
| 2013 Q2 | 9.23 Million USD | -74.6% |
| 2013 Q1 | 36.34 Million USD | 1.2% |
| 2013 Q3 | 9.32 Million USD | 1.02% |
| 2012 Q1 | 33.3 Million USD | 1.16% |
| 2012 Q4 | 35.91 Million USD | 1.16% |
| 2012 FY | 35.91 Million USD | 9.09% |
| 2012 Q3 | 35.5 Million USD | 0.86% |
| 2012 Q2 | 35.2 Million USD | 5.7% |
| 2011 FY | 32.92 Million USD | -3.72% |
| 2011 Q4 | 32.92 Million USD | 5.81% |
| 2011 Q3 | 31.11 Million USD | 1.68% |
| 2011 Q2 | 30.6 Million USD | 6.01% |
| 2011 Q1 | 28.86 Million USD | -15.58% |
| 2010 Q3 | 49.64 Million USD | 0.62% |
| 2010 Q1 | 49.94 Million USD | 0.61% |
| 2010 Q2 | 49.33 Million USD | -1.21% |
| 2010 Q4 | 34.19 Million USD | -31.12% |
| 2010 FY | 34.19 Million USD | -31.11% |
| 2009 Q2 | 49.01 Million USD | -22.57% |
| 2009 Q3 | 48.11 Million USD | -1.84% |
| 2009 Q4 | 49.64 Million USD | 3.18% |
| 2009 FY | 49.64 Million USD | -26.98% |
| 2009 Q1 | 63.3 Million USD | -6.88% |
| 2008 FY | 67.98 Million USD | -12.33% |
| 2008 Q4 | 67.98 Million USD | -13.56% |
| 2008 Q3 | 78.64 Million USD | 0.0% |
| 2008 Q2 | 78.64 Million USD | 1.41% |
| 2008 Q1 | 77.54 Million USD | 0.0% |
| 2007 Q3 | 76.49 Million USD | 0.0% |
| 2007 FY | 77.54 Million USD | 2.74% |
| 2007 Q1 | 75.47 Million USD | 0.0% |
| 2007 Q4 | 77.54 Million USD | 1.38% |
| 2007 Q2 | 76.49 Million USD | 1.34% |
| 2006 FY | 75.47 Million USD | 1710.17% |
| 2006 Q4 | 75.47 Million USD | 49.88% |
| 2006 Q3 | 50.35 Million USD | -1.65% |
| 2006 Q2 | 51.2 Million USD | -2.83% |
| 2006 Q1 | 52.69 Million USD | 1163.74% |
| 2005 Q1 | 58.5 Million USD | 489.66% |
| 2005 Q4 | 4.16 Million USD | -92.5% |
| 2005 Q2 | 57.07 Million USD | -2.45% |
| 2005 FY | 4.16 Million USD | -57.97% |
| 2005 Q3 | 55.62 Million USD | -2.53% |
| 2004 Q2 | 12.71 Million USD | -9.75% |
| 2004 FY | 9.92 Million USD | -37.47% |
| 2004 Q3 | 11.32 Million USD | -10.92% |
| 2004 Q4 | 9.92 Million USD | -12.38% |
| 2004 Q1 | 14.08 Million USD | -11.23% |
| 2003 Q3 | 12.38 Million USD | 5417.11% |
| 2003 Q1 | 285.2 Thousand USD | -48.23% |
| 2003 FY | 15.86 Million USD | 2780.4% |
| 2003 Q4 | 15.86 Million USD | 28.11% |
| 2003 Q2 | 224.5 Thousand USD | -21.28% |
| 2002 Q4 | 550.87 Thousand USD | -53.85% |
| 2002 Q1 | 5.38 Million USD | -11.67% |
| 2002 Q2 | 2.11 Million USD | -60.79% |
| 2002 Q3 | 1.19 Million USD | -43.44% |
| 2002 FY | 550.87 Thousand USD | -90.96% |
| 2001 Q1 | 4.48 Million USD | -9.99% |
| 2001 Q2 | 3.93 Million USD | -12.27% |
| 2001 FY | 6.09 Million USD | 22.45% |
| 2001 Q4 | 6.09 Million USD | -7.95% |
| 2001 Q3 | 6.62 Million USD | 68.45% |
| 2000 Q2 | 2.57 Million USD | -7.18% |
| 2000 FY | 4.97 Million USD | 65.92% |
| 2000 Q3 | 2.36 Million USD | -8.03% |
| 2000 Q4 | 4.97 Million USD | 110.1% |
| 2000 Q1 | 2.77 Million USD | 0.0% |
| 1999 FY | 3 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 27.48 Million USD | -1174.317% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -56209.375% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1270.504% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -151.921% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -393.471% |
| Fortress Biotech, Inc. | 88.59 Million USD | -295.347% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -43225.722% |
| Novavax, Inc. | 280.63 Million USD | -24.805% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2324.855% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -6320.642% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1127.168% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -413.331% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -236.187% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 86.944% |
| AlloVir, Inc. | 27.42 Million USD | -1176.919% |
| Aptorum Group Limited | 3.36 Million USD | -10316.557% |
| Ardelyx, Inc. | 55.98 Million USD | -525.64% |
| Bicycle Therapeutics plc | 44.95 Million USD | -679.086% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -245.465% |
| Chimerix, Inc. | 2.14 Million USD | -16236.101% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1577.083% |
| CRISPR Therapeutics AG | 238.63 Million USD | -46.772% |
| Clearside Biomedical, Inc. | 43 Million USD | -714.507% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1020.142% |
| Dyadic International, Inc. | 136.92 Thousand USD | -255686.576% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1062.179% |
| Fortress Biotech, Inc. | 88.59 Million USD | -295.347% |
| GT Biopharma, Inc. | 58 Thousand USD | -603772.414% |
| Alkermes plc | 290.73 Million USD | -20.471% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Innoviva, Inc. | 449.07 Million USD | 22.007% |
| IO Biotech, Inc. | 2.49 Million USD | -13943.545% |
| Jaguar Health, Inc. | 35.86 Million USD | -876.704% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -5581.2% |
| ContextLogic Inc. | 6 Million USD | -5737.433% |
| AbCellera Biologics Inc. | 77.38 Million USD | -352.631% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -149277.108% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -204.11% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -198.863% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2599.183% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -217.373% |
| NextCure, Inc. | 6.6 Million USD | -5202.74% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -5239.93% |
| ChromaDex Corporation | 3.27 Million USD | -10588.007% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -12095.195% |
| Incyte Corporation | 38.28 Million USD | -814.791% |
| Opthea Limited | 200.62 Million USD | -74.574% |
| MiMedx Group, Inc. | 48.09 Million USD | -628.177% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -885.075% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -4886.418% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -4473.956% |
| Vaxcyte, Inc. | 29.22 Million USD | -1098.488% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1368.437% |
| Pharming Group N.V. | 171.54 Million USD | -104.172% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -3442.93% |
| Acelyrin, Inc. | 1.19 Million USD | -29233.836% |
| PureTech Health plc | 25.51 Million USD | -1272.868% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1541.958% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -3455.075% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -77633.809% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -435919.819% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -478.164% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1139.414% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -819.184% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -38558.499% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -21088.506% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -120823.344% |
| Summit Therapeutics Inc. | 106.09 Million USD | -230.112% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -5541.849% |
| Senti Biosciences, Inc. | 37.66 Million USD | -829.873% |
| ImmuCell Corporation | 11.96 Million USD | -2826.202% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -464.23% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1327.129% |
| Precigen, Inc. | 7.09 Million USD | -4835.128% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -73636.0% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -110040.252% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -5024.301% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -52.818% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -346678.218% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -160.398% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -669.602% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -16421.038% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -163566.355% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1981.081% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -990.498% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -238.284% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -36082.438% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -66.672% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -9746.669% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -20661.47% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -116371.465% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1298.634% |
| Aptose Biosciences Inc. | 1 Million USD | -34584.484% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -4046180.037% |
| Soligenix, Inc. | 3.49 Million USD | -9922.604% |
| Century Therapeutics, Inc. | 48.17 Million USD | -627.089% |
| Kura Oncology, Inc. | 17.2 Million USD | -1936.314% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -278.919% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -221574.684% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -16190.512% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2406.412% |
| Autolus Therapeutics plc | 52.96 Million USD | -561.253% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -6304.206% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -737.048% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -52.658% |
| GRI Bio, Inc. | 14 Thousand USD | -2501657.143% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2719.108% |
| IGM Biosciences, Inc. | 40.5 Million USD | -764.677% |
| INmune Bio, Inc. | 10.43 Million USD | -3255.811% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -94.984% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5829.279% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -428702.644% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -42259.381% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -576.477% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -500.961% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -505.208% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 27.16% |
| Verastem, Inc. | 41.55 Million USD | -742.809% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -6386.037% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -2979.898% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -3469.204% |
| Histogen Inc. | 4.62 Million USD | -7477.802% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -10265.374% |
| Organovo Holdings, Inc. | 1.39 Million USD | -25025.251% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -661.376% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -6643.281% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1549.07% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1640396.487% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -314.061% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -167465.783% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1059.141% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -215679.0% |
| Apollomics, Inc. | 4.66 Million USD | -7414.396% |
| Amarin Corporation plc | 8.73 Million USD | -3908.767% |
| Mesoblast Limited | 118.92 Million USD | -194.515% |
| Turnstone Biologics Corp. | 3.21 Million USD | -10797.511% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -313.641% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -141700.0% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -258.833% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -84.394% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2253.804% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1044.071% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -215.742% |
| NLS Pharmaceutics AG | 1.63 Million USD | -21338.216% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -5613.638% |
| Gritstone bio, Inc. | 104.77 Million USD | -234.284% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -12471.644% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -716589.175% |
| Avid Bioservices, Inc. | 207.83 Million USD | -68.522% |
| Insmed Incorporated | 1.2 Billion USD | 70.91% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -5118.984% |
| OmniAb, Inc. | 25.56 Million USD | -1270.236% |
| Alector, Inc. | 38.91 Million USD | -799.959% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -63.715% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2211.702% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 26.793% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1690.898% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -454.476% |
| Immunic, Inc. | 1.33 Million USD | -26155.322% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1003.763% |
| Veracyte, Inc. | 12.63 Million USD | -2673.127% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 45.687% |
| FibroGen, Inc. | 170.45 Million USD | -105.477% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3756.91% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -171664.152% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 93.958% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -946510.811% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -8166.368% |
| TG Therapeutics, Inc. | 110.79 Million USD | -216.121% |
| Galecto, Inc. | 249 Thousand USD | -140561.044% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -20923.169% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 79.127% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -4686.743% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -6389.642% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -12471.644% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1202.95% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -677.064% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -24582.593% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -674.264% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -711.337% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -626.215% |
| Vaxxinity, Inc. | 15.16 Million USD | -2209.111% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 58.732% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -33990.586% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3097.134% |
| NexImmune, Inc. | 68.8 Thousand USD | -508911.903% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2467463.759% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 87.042% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -89248.014% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -4971.619% |
| Ainos, Inc. | 5.96 Million USD | -5773.107% |
| Pluri Inc. | 29.61 Million USD | -1082.784% |
| Prothena Corporation plc | 11.83 Million USD | -2859.409% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1287.937% |
| Celularity Inc. | 65.41 Million USD | -435.405% |
| Rallybio Corporation | 392 Thousand USD | -89248.469% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2283.437% |
| MeiraGTx Holdings plc | 89.26 Million USD | -292.371% |
| Omeros Corporation | 338.28 Million USD | -3.537% |
| Humacyte, Inc. | 58.1 Million USD | -502.771% |
| Immunocore Holdings plc | 84.03 Million USD | -316.801% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -18801.565% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -7081.587% |
| Blueprint Medicines Corporation | 774.12 Million USD | 54.756% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -6879.793% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -466.576% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -236.464% |
| Pulmatrix, Inc. | 8.75 Million USD | -3900.069% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -4963.554% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2428.852% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -203.648% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1010.2% |
| Cytokinetics, Incorporated | 755.77 Million USD | 53.657% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2516.901% |
| Nutriband Inc. | 241.28 Thousand USD | -145058.63% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -6306.548% |
| Vor Biopharma Inc. | 35.66 Million USD | -882.182% |
| Roivant Sciences Ltd. | 499.74 Million USD | 29.916% |
| Evogene Ltd. | 1.13 Million USD | -30677.329% |
| ProKidney Corp. | 4.41 Million USD | -7836.687% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -28468.189% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -634806.191% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 79.869% |
| CorMedix Inc. | 667.63 Thousand USD | -52360.937% |
| BioLineRx Ltd. | 11.59 Million USD | -2921.706% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -799.913% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -387.76% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2025.795% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -14189.946% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -51788.296% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -665.18% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -538740.0% |
| MediciNova, Inc. | 215.92 Thousand USD | -162106.497% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -13937.916% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -27674.641% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -87.928% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3301.768% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 15.609% |
| Mereo BioPharma Group plc | 5.95 Million USD | -5784.509% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -9656.156% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -21321.774% |
| Absci Corporation | 15.95 Million USD | -2094.936% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3723.229% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2287.336% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1177.571% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -2757.285% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2700.624% |
| Allakos Inc. | 41.46 Million USD | -744.679% |
| Imunon, Inc. | 1.62 Million USD | -21457.394% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3136.725% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -231850.993% |
| BioAtla, Inc. | 2.46 Million USD | -14137.642% |
| NLS Pharmaceutics AG | 1.63 Million USD | -21338.216% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -309852.212% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -268.211% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -6215.29% |
| XOMA Corporation | 124.45 Million USD | -181.435% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1749.923% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -711.374% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2220.278% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3044.604% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1244.876% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1564.035% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -100257.02% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -107175.194% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -21364.769% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 76.639% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -213507.616% |
| UroGen Pharma Ltd. | 100.21 Million USD | -249.498% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -91.654% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -101027.21% |
| Orgenesis Inc. | 22.62 Million USD | -1448.322% |
| Entera Bio Ltd. | 390 Thousand USD | -89706.667% |
| GH Research PLC | 343 Thousand USD | -102012.536% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -114734.754% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -35896.506% |
| Xencor, Inc. | 83.43 Million USD | -319.788% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -202737.734% |
| Replimune Group, Inc. | 75.86 Million USD | -361.646% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -28509.587% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -3624.436% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -213507.616% |
| Portage Biotech Inc. | 47 Thousand USD | -745104.255% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -27674.641% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -14390.939% |
| OncoCyte Corporation | 2.86 Million USD | -12107.947% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -26858.258% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -232538.123% |
| Purple Biotech Ltd. | 351 Thousand USD | -99685.185% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -10987.243% |
| scPharmaceuticals Inc. | 40.26 Million USD | -769.766% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -584.168% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -246552.113% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -6595.584% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1209.918% |
| Curis, Inc. | 2.79 Million USD | -12435.648% |
| Daré Bioscience, Inc. | 5.31 Million USD | -6485.868% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -16293.839% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -61890.442% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1993.395% |
| BeiGene, Ltd. | 930.18 Million USD | 62.347% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2153.473% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -298.26% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -30596.407% |
| Erasca, Inc. | 55.85 Million USD | -527.018% |
| bluebird bio, Inc. | 330.32 Million USD | -6.03% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 69.111% |
| DBV Technologies S.A. | 14.38 Million USD | -2335.477% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -13898.641% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -2763.827% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -7441.904% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 13.473% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -660.759% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -7499.176% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -13678.363% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1757.773% |
| MacroGenics, Inc. | 33.97 Million USD | -931.015% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1573.896% |
| Prime Medicine, Inc. | 13.63 Million USD | -2469.104% |
| Aditxt, Inc. | 18.21 Million USD | -1822.529% |
| Adagene Inc. | 22.3 Million USD | -1470.126% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2188.741% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 42.673% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1625.945% |
| SciSparc Ltd. | 76 Thousand USD | -460750.0% |
| Vericel Corporation | 88.14 Million USD | -297.361% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -327.042% |
| Generation Bio Co. | 97.89 Million USD | -257.781% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -106357.751% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1284.481% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -70.092% |
| Invivyd, Inc. | 2.16 Million USD | -16077.644% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -555.082% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -9939537.827% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -6218.708% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -555846.032% |
| 2seventy bio, Inc. | 256.67 Million USD | -36.456% |
| ADMA Biologics, Inc. | 141.41 Million USD | -147.667% |
| Clene Inc. | 32.16 Million USD | -989.04% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -6140.848% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -15856.538% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -591.202% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -72679.146% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -81.294% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1062.604% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1936.669% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -181.232% |
| Evaxion Biotech A/S | 10.86 Million USD | -3122.229% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -320.015% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -367.574% |
| Trevena, Inc. | 35.23 Million USD | -894.085% |
| Surrozen, Inc. | 3.37 Million USD | -10265.374% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -5291.718% |
| Cingulate Inc. | 3.13 Million USD | -11071.768% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -854158.537% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1197.688% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -69822.919% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -57983.914% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -512.265% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -75221.72% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1138.844% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1632.262% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -22423.859% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -27697.302% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2053.884% |
| ImmunityBio, Inc. | 883.67 Million USD | 60.365% |
| Korro Bio, Inc. | 33.2 Million USD | -954.735% |
| Kineta, Inc. | 1.31 Million USD | -26494.229% |
| BioVie Inc. | 6.11 Million USD | -5630.983% |
| Codexis, Inc. | 22.36 Million USD | -1466.115% |
| Celularity Inc. | 65.41 Million USD | -435.405% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -577.092% |
| Celcuity Inc. | 37.44 Million USD | -835.329% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -156050.691% |
| Cibus, Inc. | 24.62 Million USD | -1322.55% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -91348.042% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1701.214% |
| IN8bio, Inc. | 4.89 Million USD | -7058.103% |
| Kodiak Sciences Inc. | 181.63 Million USD | -92.833% |
| Annexon, Inc. | 31.35 Million USD | -1017.034% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -366.771% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -14854.996% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -8873.764% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 75.904% |
| Eyenovia, Inc. | 16.1 Million USD | -2074.393% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -214.15% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -35457.97% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -2957.048% |
| Arcellx, Inc. | 97.62 Million USD | -258.767% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -16198.092% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1221.035% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -11190.974% |
| Moolec Science SA | 2.64 Million USD | -13140.368% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1129.494% |
| Geron Corporation | 85.89 Million USD | -307.742% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -5448.012% |
| Royalty Pharma plc | 6.13 Billion USD | 94.291% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -14481.432% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -303790.537% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -935.312% |
| Humacyte, Inc. | 58.1 Million USD | -502.771% |
| Structure Therapeutics Inc. | 5.45 Million USD | -6322.995% |
| 89bio, Inc. | 27.1 Million USD | -1192.039% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2536.204% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -13804.168% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -26076.831% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -230.221% |
| Notable Labs, Ltd. | 2.04 Million USD | -16993.509% |
| Liquidia Corporation | 3.5 Million USD | -9898.458% |
| Mustang Bio, Inc. | 2.49 Million USD | -13921.057% |
| Immunovant, Inc. | 138 Thousand USD | -253701.449% |
| Quantum-Si incorporated | 15.3 Million USD | -2188.741% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -3916.122% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -87461.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -552.13% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -428702.644% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3112.382% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -166296.344% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -172434.975% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1595.204% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -86809.677% |
| PepGen Inc. | 20.1 Million USD | -1642.171% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -60918.467% |
| United Therapeutics Corporation | 700 Million USD | 49.965% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1233.508% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -7747.843% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -39431.151% |
| XOMA Corporation | 124.45 Million USD | -181.435% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -127727.007% |
| Bionomics Limited | 239.61 Million USD | -46.168% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -17119.576% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2538.189% |
| uniQure N.V. | 138.4 Million USD | -153.051% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -310.014% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -33838.566% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -35457.97% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -3756.91% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -19948.426% |
| Altimmune, Inc. | 671 Thousand USD | -52097.615% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 21.303% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2538.189% |
| Compugen Ltd. | 1.35 Million USD | -25824.944% |
| Peak Bio, Inc. | 10.72 Million USD | -3166.67% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -718.982% |
| Benitec Biopharma Inc. | 284 Thousand USD | -123226.056% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -314.223% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1658.175% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -2873.478% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -282.958% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1658.175% |
| Instil Bio, Inc. | 86.05 Million USD | -307.007% |
| argenx SE | 20 Million USD | -1651.23% |
| Immunome, Inc. | 1.65 Million USD | -21127.03% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -20110.387% |
| Verona Pharma plc | 51.32 Million USD | -582.355% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -3481.98% |
| Shattuck Labs, Inc. | 4.2 Million USD | -8235.221% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -96653.039% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -8277.087% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -59771.111% |
| Moolec Science SA | 2.64 Million USD | -13140.368% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1059.4% |
| AnaptysBio, Inc. | 17.81 Million USD | -1866.128% |
| Design Therapeutics, Inc. | 3.05 Million USD | -11383.475% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -133581.679% |
| NeurAxis, Inc. | 224.26 Thousand USD | -156078.543% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2361.667% |
| Lumos Pharma, Inc. | 6.58 Million USD | -5218.846% |
| Achilles Therapeutics plc | 4.61 Million USD | -7489.296% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -3481.98% |
| 180 Life Sciences Corp. | 1.32 Million USD | -26432.401% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1950.606% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -22423.859% |
| Nutriband Inc. | 241.28 Thousand USD | -145058.63% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3329.413% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -42302.663% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 6.281% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1063.647% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -9371.571% |
| Palisade Bio, Inc. | 369 Thousand USD | -94817.615% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -84296.627% |
| Beam Therapeutics Inc. | 173.17 Million USD | -102.252% |
| Neurogene Inc. | 16.25 Million USD | -2054.697% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -13.664% |
| AEON Biopharma, Inc. | 278 Thousand USD | -125887.77% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -104451.045% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -327566.501% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -361.688% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -473.168% |
| Athira Pharma, Inc. | 1.58 Million USD | -21997.539% |
| Vaccinex, Inc. | 247 Thousand USD | -141700.0% |
| HCW Biologics Inc. | 6.45 Million USD | -5328.675% |
| XOMA Corporation | 124.45 Million USD | -181.435% |
| Nektar Therapeutics | 230.4 Million USD | -52.016% |
| Arvinas, Inc. | 3.4 Million USD | -10201.353% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -21364.769% |
| Merus N.V. | 12.16 Million USD | -2779.839% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -172.718% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2435.442% |
| Rezolute, Inc. | 2.22 Million USD | -15620.197% |
| Clene Inc. | 32.16 Million USD | -989.04% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -199979.976% |
| BeyondSpring Inc. | 3.99 Million USD | -8667.109% |
| Synlogic, Inc. | 17.27 Million USD | -1927.473% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -26842.0% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1000602.857% |
| Peak Bio, Inc. | 10.72 Million USD | -3166.67% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -574.549% |
| Krystal Biotech, Inc. | 8.09 Million USD | -4227.231% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -97.861% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -4863.1% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -256313.898% |
| MannKind Corporation | 382.37 Million USD | 8.403% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3161.743% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -85534.719% |
| Gossamer Bio, Inc. | 212.46 Million USD | -64.85% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -201190.805% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -3723.229% |
| Legend Biotech Corporation | 328.67 Million USD | -6.564% |
| Mural Oncology plc | 15 Million USD | -2233.573% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -638.511% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -16570.443% |
| Champions Oncology, Inc. | 7.43 Million USD | -4613.943% |
| REGENXBIO Inc. | 89.29 Million USD | -292.257% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -40878.967% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -63237.685% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -6369.265% |
| Vaxart, Inc. | 26.51 Million USD | -1220.985% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2136.942% |
| Cellectis S.A. | 92.85 Million USD | -277.205% |
| Longeveron Inc. | 2.04 Million USD | -17060.51% |
| Repare Therapeutics Inc. | 3.41 Million USD | -10171.144% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 74.925% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -651.73% |
| Revolution Medicines, Inc. | 87.94 Million USD | -298.26% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -202354.335% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -8760.258% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -110387.697% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -200040.571% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 56.674% |
| Denali Therapeutics Inc. | 52.24 Million USD | -570.443% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2331.341% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -25390.975% |
| Cingulate Inc. | 3.13 Million USD | -11071.768% |
| Passage Bio, Inc. | 26.29 Million USD | -1232.038% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -5155.004% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -85744.608% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -39077.405% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1603.448% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -27697.302% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -14189.217% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -11115.05% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -43086.93% |
| OmniAb, Inc. | 25.56 Million USD | -1270.236% |
| Anew Medical, Inc. | 1.6 Million USD | -21722.181% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1083.949% |
| Lipocine Inc. | 17.16 Thousand USD | -2040247.198% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -2909.503% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -911.453% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -5829.279% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -512.607% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -172434.975% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -6681.142% |
| Ocugen, Inc. | 6.94 Million USD | -4946.045% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2378.916% |
| Q32 Bio Inc. | 1.31 Million USD | -26474.052% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -52019.94% |
| Alumis Inc. Common Stock | 32.58 Million USD | -975.034% |
| Equillium, Inc. | 824 Thousand USD | -42405.583% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -3757.76% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -116335.842% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -129.973% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -584.904% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -45090.233% |
| Dominari Holdings Inc. | 3.02 Million USD | -11466.909% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -370581.681% |
| vTv Therapeutics Inc. | 529 Thousand USD | -66109.074% |
| Bio-Techne Corporation | 419.53 Million USD | 16.516% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -386.48% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -80.944% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1973.934% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1438.731% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -5681.545% |
| Nkarta, Inc. | 88.33 Million USD | -296.479% |
| BioCardia, Inc. | 1.31 Million USD | -26534.677% |
| Iterum Therapeutics plc | 19.5 Million USD | -1695.305% |